October 20, 2021

The Indie Toaster

Complete News World

Govt: WHO warns of link between MRNA vaccines and heart problems – 07/09/2021

A report released this Friday (9) by the WHO (World Health Organization) highlights the “potential” link between inflammation in the heart and injections. Vaccines against Govt-19 Who use Ambassador RNA technology. However, the WHO emphasized that the benefits outweigh the risks.

Experts from the WHO Global Advisory Council on Immunization Protection explain that heart attack – inflammation of the heart muscle – and pericarditis – inflammation of the membranes surrounding the heart – have been reported in many countries, especially in the United States.

“In the days following vaccination, reported cases occurred mostly among young people, especially after the second dose of the Covit-19 messenger RNA vaccine,” the report said.

After reviewing the data available to date, the WHO concludes that “current data indicate a possible link between myocarditis and messenger RNA vaccines.” However, according to the company, “the benefits of messenger RNA vaccines outweigh the risks of hospitalization and reduction in deaths from Covit-19 infections.”

The WHO further explains that the onset of myocarditis and pericarditis immediately after vaccination is usually mild and responsive to treatment. “A study is underway to determine the long-term effects,” the experts added, adding that they will continue to assess the situation to update their recommendations.

The Americans had already warned of the problem

As of June 23, U.S. health officials have already made the recommendation There was an “opportunity” link between the Covit-19 vaccines Pfizer And modern – messenger RNA vaccines – and rare cases of inflammation of the heart among adolescents and young adults, but the benefits of these vaccines still “exaggerate” the risks.

See also  What would a hurricane look like from the inside? See pictures created by Sea Drone - 03/10/2021

According to the World Health Organization, the EMA (European Pharmaceuticals Institute) Pharmacovigilance Risk Assessment Group examined recent data from Europe at a July 5 to 8 meeting to confirm the existence of a reliable causal link between myocarditis and messenger RNA vaccines.

Myocarditis is a rare disease that experts believe is usually triggered by a virus. The most common symptom is chest pain and is usually treated with anti-inflammatory drugs or oxygen if needed.

The first cases of myocarditis were reported in Israel, where the immunization campaign was faster than in most countries.

(With information from AFP)